No Data
No Data
Morgan Stanley Maintains Ginkgo Bioworks(DNA.US) With Hold Rating, Maintains Target Price $10
After Plunging -52.33% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA)
Ginkgo Bioworks Holdings: Balancing Growth and Uncertainty With a Hold Rating
BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Maintains Target Price $6
Ginkgo Bioworks Holdings Full Year 2024 Earnings: EPS Misses Expectations
Ginkgo Bioworks Falls -12.5%